Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Joseph Frank Merola, M.D.

Co-Author

This page shows the publications co-authored by Joseph Merola and Sebastian Schneeweiss.
Connection Strength

1.220
  1. Incidence of Bacterial and Nonbacterial Conjunctivitis in Patients With Atopic Dermatitis Treated With Dupilumab: A US Multidatabase Cohort Study. Dermatitis. 2022 Feb 15.
    View in: PubMed
    Score: 0.239
  2. Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases. JAMA Dermatol. 2021 Jul 01; 157(7):805-816.
    View in: PubMed
    Score: 0.229
  3. Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: A propensity score-matched cohort study. J Am Acad Dermatol. 2021 Feb; 84(2):300-311.
    View in: PubMed
    Score: 0.218
  4. Serious infection risk in children with psoriasis on systemic treatment: A propensity score-matched population-based study. J Am Acad Dermatol. 2020 Jun; 82(6):1337-1345.
    View in: PubMed
    Score: 0.209
  5. Risk of Inflammatory Arthritis After a New Diagnosis of Hidradenitis Suppurativa. JAMA Dermatol. 2020 03 01; 156(3):342-345.
    View in: PubMed
    Score: 0.209
  6. Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study. Br J Dermatol. 2022 Jun 19.
    View in: PubMed
    Score: 0.061
  7. Risk of connective tissue disease, morphoea and systemic vasculitis in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2021 Jan; 35(1):195-202.
    View in: PubMed
    Score: 0.054
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.